36 filings
Page 2 of 2
6-K
6191ayl 58z
2 May 19
Kitov Announces Retirement of Founder and Executive Chairman Dr. Paul Waymack
4:46pm
6-K
pkcfhmlruegj1vrz
29 Apr 19
Report of Foreign Private Issuer
4:29pm
6-K
93nz9m uflxih
15 Apr 19
Report of Foreign Private Issuer
7:20am
6-K
euspss8lj0fikz5iu18
12 Apr 19
Report of Foreign Private Issuer
4:04pm
6-K
tmnm9stsx c8i3h0di
8 Apr 19
Proxy Statement - Annex A1
6:38am
6-K
vzh07c
1 Apr 19
Report of Foreign Private Issuer
6:47am
6-K
tn3pk484xi lp6r6
22 Mar 19
Report of Foreign Private Issuer
4:30pm
6-K
vqdxk8o5e 1bhur
14 Mar 19
Notice of Special General Meeting of Shareholders
5:19pm
6-K
kpic9a 014m71a6
14 Mar 19
Kitov to Acquire Clinical Stage Candidate CM-24 Creating a Transformational Immuno-Oncology Company
9:28am
6-K
h6r7 lontz7zm
11 Feb 19
Thank you CORPORATE PRESENTATION February 2019
4:47pm
6-K
4mrd96rz484p lvfbw
7 Feb 19
Kitov Pharma Reports Year End 2018 Financial Results and Provides Business Update
8:08am
6-K
bmqpyyggbzrm29 7m
18 Jan 19
Kitov Closes $6 Million Registered Direct Offering
5:22pm
6-K
i6ihqe3xjdfm4fcc
18 Jan 19
Report of Foreign Private Issuer
11:58am
6-K
505lqed
16 Jan 19
Kitov Announces Pricing of $6 Million Registered Direct Offering
4:05pm
6-K
3pwhoh gme3l
15 Jan 19
Report of Foreign Private Issuer
5:15pm
6-K
p5hj6kaa
3 Jan 19
Kitov Signs Marketing and Distribution Agreement for its Lead Product Consensiā¢ in the U.S. with Coeptis Pharmaceuticals
7:20am